Milton H. Werner

Insider Reports History

Entity
Individual
Location
3350 Riverwood Parkway Se, Suite 1900, Atlanta, GA
Signature
/s/ Milton H. Werner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Milton H. Werner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inhibikase Therapeutics, Inc. President and CEO, Director, 10%+ Owner Stock Option (right to buy) 45K Apr 1, 2024 Direct

Insider Reports Filed by Milton H. Werner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IKT Inhibikase Therapeutics, Inc. Apr 1, 2024 1 $0 4 Apr 3, 2024 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. Aug 16, 2022 1 $4K 4 Aug 16, 2022 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. May 27, 2022 1 $4.88K 4 May 31, 2022 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. May 20, 2022 1 $6K 4 May 23, 2022 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. Mar 7, 2022 1 $0 4 Mar 21, 2022 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. Mar 7, 2022 1 $0 4 Mar 9, 2022 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. Jan 3, 2022 2 $44.1K 4 Jan 4, 2022 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. Nov 17, 2021 5 $46.6K 4 Nov 19, 2021 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. Aug 17, 2021 2 $44.1K 4 Aug 19, 2021 President and CEO, Director, 10%+ Owner
IKT Inhibikase Therapeutics, Inc. May 14, 2021 3 -$61K 4 May 18, 2021 President and CEO, Director, 10%+ Owner